Trial intelligence / Profile preview

GLUCOVAS trial of insulin-based glycemic control, continuous tube feeding, and vildagliptin in acute ischemic stroke with hyperglycemia

NL-OMON25157Not yet recruiting

Sponsor
AMC Health
Start
Jul 2009
Modality
Small Molecules, Recombinant Proteins and Enzymes
Countries
1
01

Overview

Randomised trial of vildagliptin and human insulin in ischemic stroke (4 arms), sponsored by AMC Health. Primary endpoints: Glycemic control and Hypoglycemia. Planned start Jul 2009; status: not yet recruiting.

02

Drugs

vildagliptinhuman insulin
03

Conditions

ischemic stroke

Beyond the preview

Go deeper on NL-OMON25157.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON25157.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call